CN106591364A - Method for obtaining transgenic bovine fetal fibroblast by use of single Cas9 nickase for mediation of fixed point insertion of NRAMP1 - Google Patents
Method for obtaining transgenic bovine fetal fibroblast by use of single Cas9 nickase for mediation of fixed point insertion of NRAMP1 Download PDFInfo
- Publication number
- CN106591364A CN106591364A CN201611001075.7A CN201611001075A CN106591364A CN 106591364 A CN106591364 A CN 106591364A CN 201611001075 A CN201611001075 A CN 201611001075A CN 106591364 A CN106591364 A CN 106591364A
- Authority
- CN
- China
- Prior art keywords
- nramp1
- genes
- cattle
- sequence
- site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000283690 Bos taurus Species 0.000 title claims abstract description 75
- 108091006619 SLC11A1 Proteins 0.000 title claims abstract description 54
- 102100034559 Natural resistance-associated macrophage protein 1 Human genes 0.000 title claims abstract description 47
- 108091033409 CRISPR Proteins 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 34
- 230000001605 fetal effect Effects 0.000 title claims abstract description 28
- 210000002950 fibroblast Anatomy 0.000 title claims abstract description 28
- 108010008532 Deoxyribonuclease I Proteins 0.000 title claims abstract description 17
- 102000007260 Deoxyribonuclease I Human genes 0.000 title claims abstract description 17
- 238000003780 insertion Methods 0.000 title claims abstract description 16
- 230000037431 insertion Effects 0.000 title claims abstract description 16
- 230000009261 transgenic effect Effects 0.000 title abstract description 20
- 239000013598 vector Substances 0.000 claims abstract description 38
- 230000008685 targeting Effects 0.000 claims abstract description 34
- 239000013604 expression vector Substances 0.000 claims abstract description 15
- 238000010354 CRISPR gene editing Methods 0.000 claims abstract description 13
- 238000004520 electroporation Methods 0.000 claims abstract description 6
- 210000004027 cell Anatomy 0.000 claims description 44
- 108090000623 proteins and genes Proteins 0.000 claims description 40
- 210000002540 macrophage Anatomy 0.000 claims description 17
- 210000000349 chromosome Anatomy 0.000 claims description 16
- 108700019146 Transgenes Proteins 0.000 claims description 13
- 101001021925 Homo sapiens Fascin Proteins 0.000 claims description 12
- 102100036089 Fascin Human genes 0.000 claims description 11
- 101000756632 Homo sapiens Actin, cytoplasmic 1 Proteins 0.000 claims description 10
- 230000010354 integration Effects 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000003321 amplification Effects 0.000 claims description 6
- 238000003776 cleavage reaction Methods 0.000 claims description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 6
- 230000007017 scission Effects 0.000 claims description 6
- 238000013518 transcription Methods 0.000 claims description 6
- 230000035897 transcription Effects 0.000 claims description 6
- 238000010276 construction Methods 0.000 claims description 5
- 210000003754 fetus Anatomy 0.000 claims description 5
- 238000011144 upstream manufacturing Methods 0.000 claims description 5
- 230000006801 homologous recombination Effects 0.000 claims description 4
- 238000002744 homologous recombination Methods 0.000 claims description 4
- 238000010449 nuclear transplantation Methods 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 101150087690 ACTB gene Proteins 0.000 claims 1
- 101150009602 mesh gene Proteins 0.000 claims 1
- 230000014509 gene expression Effects 0.000 abstract description 8
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 abstract description 8
- 238000002105 Southern blotting Methods 0.000 abstract description 5
- 210000001161 mammalian embryo Anatomy 0.000 abstract description 5
- 101150067862 NRAMP1 gene Proteins 0.000 abstract description 4
- 238000007877 drug screening Methods 0.000 abstract description 4
- 229950010131 puromycin Drugs 0.000 abstract description 4
- 210000001728 clone cell Anatomy 0.000 abstract description 3
- 210000001539 phagocyte Anatomy 0.000 abstract description 2
- 210000004291 uterus Anatomy 0.000 abstract description 2
- 230000004083 survival effect Effects 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 53
- 230000008569 process Effects 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 238000010363 gene targeting Methods 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 238000000137 annealing Methods 0.000 description 8
- 239000012531 culture fluid Substances 0.000 description 8
- 230000001186 cumulative effect Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
- 210000000287 oocyte Anatomy 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 239000000969 carrier Substances 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 238000013459 approach Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 210000002257 embryonic structure Anatomy 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000035800 maturation Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 101710163270 Nuclease Proteins 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 230000007159 enucleation Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 239000012124 Opti-MEM Substances 0.000 description 3
- 108091027544 Subgenomic mRNA Proteins 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 101150024923 da gene Proteins 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 239000012096 transfection reagent Substances 0.000 description 3
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 239000012930 cell culture fluid Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000005138 cryopreservation Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 2
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 210000004508 polar body Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 238000010374 somatic cell nuclear transfer Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 206010006049 Bovine Tuberculosis Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 108091029795 Intergenic region Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 108091006207 SLC-Transporter Proteins 0.000 description 1
- 102000037054 SLC-Transporter Human genes 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 101150063416 add gene Proteins 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000004691 chief cell of stomach Anatomy 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000030944 contact inhibition Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 210000001771 cumulus cell Anatomy 0.000 description 1
- JVHIPYJQMFNCEK-UHFFFAOYSA-N cytochalasin Natural products N1C(=O)C2(C(C=CC(C)CC(C)CC=C3)OC(C)=O)C3C(O)C(=C)C(C)C2C1CC1=CC=CC=C1 JVHIPYJQMFNCEK-UHFFFAOYSA-N 0.000 description 1
- ZMAODHOXRBLOQO-UHFFFAOYSA-N cytochalasin-A Natural products N1C(=O)C23OC(=O)C=CC(=O)CCCC(C)CC=CC3C(O)C(=C)C(C)C2C1CC1=CC=CC=C1 ZMAODHOXRBLOQO-UHFFFAOYSA-N 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 230000011559 double-strand break repair via nonhomologous end joining Effects 0.000 description 1
- 108010030074 endodeoxyribonuclease MluI Proteins 0.000 description 1
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000003328 fibroblastic effect Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- BXJVBCCMZKYRGE-UHFFFAOYSA-N n,n-dimethyl-7h-purin-2-amine Chemical compound CN(C)C1=NC=C2NC=NC2=N1 BXJVBCCMZKYRGE-UHFFFAOYSA-N 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000013120 recombinational repair Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000004340 zona pellucida Anatomy 0.000 description 1
- 206010048282 zoonosis Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0656—Adult fibroblasts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/101—Bovine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a method for obtaining a transgenic bovine fetal fibroblast by use of single Cas9 nickase for mediation of fixed point insertion of NRAMP1, according to the method, an electroporation method is used for co-transfecting a bovine fetal fibroblast with a donor vector and a single CRISPR /Cas9 nickase expression vector aiming at a targeting site, a NRAMP1 gene self promoter in the donor vector enables specific expression of the NRAMP1 in a professional phagocyte, and after puromycin drug screening, a targeting positive clone cell can be obtained by PCR and Southern Blotting identification. A transgenic cloned embryo can be obtained from the transgenic positive clone cell as a nuclear donor, and a survival NRAMP1-fixed-point-inserted transgenic cloned cow can be finally obtained by further transplantation of the transgenic cloned embryo into a uterus of a rutting receptor cow.
Description
Technical field
The invention belongs to technology of gene conversion and animal clone field, is related to the structure of the nuclear donor cell of transgene clone cattle,
It is more particularly to a kind of to mediate the bovine fetal fibroblast that the gene site-directed insertions of NRAMP1 obtain target practice thin using single Cas9 nickases
The method of born of the same parents.
Background technology
Tuberculosis be it is a kind of by Mycobacterium tuberculosiss (Mycobacterium tuberculosis, MTB) people and cattle it
Between propagate the worldwide zoonosiss for causing, Animal husbandry production safety, livestock product safety or even human health are caused sternly
Threaten again.
NRAMP1 (natural resistance-associated macrophage protein-1) also known as SLC11A1
(solute carrier family 11A member 1), is the first related to tubercule bacillus susceptibility of researcher discovery
Gene (Vidal S et al, 1995).When tubercule bacillus invade macrophage, NRAMP1 is by participating in innate immunity process
(Hedges JF, 2013) so as to suppress tubercule bacillus in the propagation of intracellular, are produced anti-to promote NO to produce with other proinflammatories
Sick effect.
2 months 2013, internationally famous periodical《Cell》The research worker for reporting University of California-San Francisco is found
A kind of accurate silent gene method, referred to as CRISPR/Cas9 mediation Knockout technology.The Technological expression goes out many superior
Property, for example can simultaneously any number of gene of silence, with excellent targeting, build that simple and cost is low.The technology
Since invention, in being applied to human cell and mice isotype zooscopy by vast China and foreign countries' research worker rapidly, become
The new focus of current Life Sci-Tech research.
Realize that the breed improvement of domestic animal has huge application potential using transgenic technology.Strengthened by transgenic technology
Domestic animal for the resistance of tubercule bacillus, for the prevention and treatment of following bovine tuberculosis are significant.However, at present
The application that the gene of CRISPR/Cas9 technologies mediation is inserted in breeding transgenic livestock is very limited.Additionally, how to ensure external source
While gene insertion efficiency, weaken the changeable effect of missing the target of the system still urgently to be resolved hurrily so far.
The content of the invention
It is an object of the invention to provide a kind of turn base using the mediation NRAMP1 fixed point insertion acquisitions of single Cas9 nickases
Because of the method for bovine fetal fibroblast, can be using single Cas9 nickases and the specific expressed target practice of NRAMP1 macrophages
Carrier obtains NRAMP1 genes in No. 25 chromosome F-A sites of cattle (i.e. specific sequence in cattle FSCN1 genes and ACTB intergenic regions
Column-slice section) site-directed integration bovine fetal fibroblast, be to develop antituberculotic to turn base using the cell as nuclear donor cell
Because cattle provides solid foundation.
To reach above-mentioned purpose, technical scheme below is present invention employs:
A kind of specific expressed targeting vector (abbreviation pNRAMP1-eGFP-P2A-Puro) of NRAMP1 macrophages, this dozen
Targeting vector includes genes of interest NRAMP1 and for NRAMP1 genes to be inserted into No. 25 chromosomes of cattle by homologous recombination fixed point
The intergenic element sequences of FSCN1 and ACTB.
The element sequences include that homology arm is with cow genome group as mould for the homology arm sequence of site homologous recombination of practicing shooting
Plate is expanded, and amplified production is respectively the upstream 577-977bp and downstream 616-1016bp in target practice site on No. 25 chromosomes of cattle;Beat
Target site is located in the sequence between No. 25 chromosome FSCN1 and ACTB genes of cattle as shown in SEQ.ID.NO.1.
The genes of interest NRAMP1 is that the NRAMP1 genes its own promoter expanded by external source starts transcription.
The element sequences also include selection markers eGFP gene and PURO genes, the two riddled basins all by
EF1 α promoteres start transcription, and are expressed by self cleavage peptide P2A sequences fused in tandem.
The element sequences also include being located at two LoxP sequences in the same direction of two riddled basins both sides.
A kind of construction method of the bovine fetal fibroblast of insertion genes of interest NRAMP1, comprises the following steps:With cattle
Fetal fibroblast is host cell, by cotransfection targeting vector pNRAMP1-eGFP-P2A-Puro and for target practice position
The single CRISPR/Cas9 nickases expression vector of point, by genes of interest NRAMP1 site-directed integrations to bovine fetal fibroblast
No. 25 chromosome FSCN1 and ACTB genes between.
The host cell is the holstein cow fetal fibroblast for passing on for 2~3 generations, to take into account cell quantity and work
Property.
The cotransfection operation adopts electroporation.
The single CRISPR/Cas9 nickases expression vector includes the go-ahead sequence corresponding with target practice site, beats
Target site is located in the sequence between No. 25 chromosome FSCN1 and ACTB genes of cattle as shown in SEQ.ID.NO.1.
The bovine fetal fibroblast of the insertion genes of interest NRAMP1 can be moved as the core of production transgene clone cattle
Plant operation donorcellses to use.
Compared with prior art, the present invention has following beneficial technique effect:
1. the present invention constructs a kind of specific expressed targeting vector pNRAMP1-eGFP-P2A- of NRAMP1 macrophages
Puro, and NRAMP1 Gene targetings are made to No. 25 chromosome F-A sites of cattle by gene targeting.The location proximate base
Because cluster is housekeeping gene, it is in enlivening expression status in different tissues.NRAMP1 is inserted into the region, can avoid its because
Heterochromatinization is modified and loss of activity.
2. the present invention constructs a kind of specific expressed targeting vector pNRAMP1-eGFP-P2A- of NRAMP1 macrophages
Puro, can mediate it to be incorporated into F-A sites by single CRISPR/Cas9 nickases.Single CRISPR/Cas9 nickases can
Nonhomologous end recombination repair (NHEJ) introduces extra mutation (indels) in genome range during to reduce target practice,
So as to reduce cytotoxicity, the safety of transgenic animal is improved.
3. the present invention constructs a kind of specific expressed targeting vector pNRAMP1-eGFP-P2A- of NRAMP1 macrophages
Puro, its genes of interest NRAMP1 start transcription by the gene its own promoter that external source is expanded.So that genes of interest
NRAMP1 and normal transcription and expression only in technical phagocyte, improve transgenic animal production safety.
4. the present invention constructs a kind of specific expressed targeting vector pNRAMP1-eGFP-P2A- of NRAMP1 macrophages
Puro, includes riddled basins PURO in the targeting vector, facilitate drug screening to obtain positive colony cell;Include sieve
Select marker gene eGFP, the convenient insertion that exogenous gene is directly determined under fluorescence microscope.Simultaneously selection markers both sides is same
The selection markers in positive colony cell can be removed to LoxP with cre enzyme collective effects.
5. the present invention obtain insertion genes of interest NRAMP1 bovine fetal fibroblast, Jing PCR and Southern
Blotting is identified, it was demonstrated that genes of interest is site-directed integration to bovine fetal fibroblast genome F-A sites.
6., to insert the bovine fetal fibroblast of genes of interest NRAMP1 as nuclear transfer donor cell, can pass through
SCNT obtains transgene clone cattle, is to obtain the new varieties transgenic cow for having tuberculosis higher resistance to lay solid base
Plinth.
Description of the drawings
Fig. 1 is the schematic diagram that the corresponding go-ahead sequence in site of practicing shooting is cloned into Cas9 expression vectors.
Fig. 2 is the collection of illustrative plates of Cas9 carrier for expression of eukaryon.
Fig. 3 is using detection figures of the Surveyor nuclease assay to Cas9 cleavage activities.
Fig. 4 is the collection of illustrative plates of targeting vector pNRAMP1-eGFP-P2A-Puro.
Fig. 5 is original cuiture (A) and the bovine fetal fibroblast for gene targeting in Secondary Culture (B).
Fig. 6 is to transfect the monoclonal cell figure that the bovine fetal fibroblast Jing puromycins of targeting vector are screened.
Fig. 7 is positive monoclonal cellular identification schematic diagram.
Fig. 8 is the junction PCR qualification result figures for choosing some representative monoclonal cells.
Fig. 9 is to be verified as there occurs that 14 monoclonal cells of NRAMP1 Gene targetings are carried out to Jing PCR
The result figure of Southern blotting checkings.
Figure 10 is the transgenic cloned embryos prepared using the positive colony cell of gene targeting.
Figure 11 is the transgene clone cattle prepared using the positive colony cell of gene targeting.
Specific embodiment
The present invention is described in further details with reference to the accompanying drawings and examples.Described is explanation of the invention, and
It is not to limit.
The present invention constructs first the specific expressed targeting vector pNRAMP1- of the macrophage containing NRAMP1 genes
EGFP-P2A-Puro, then by the method for electroporation by targeting vector pNRAMP1-eGFP-P2A-Puro and for target practice position
The single CRISPR/Cas9 nickases expression vector cotransfection bovine fetal fibroblast of point, after puromycin drug screening, Jing
Cross PCR and Southern Blotting identifications and obtain the positive colony cell practiced shooting.Positive colony cell with the target practice is as core
Donor is moved in cattle enucleation oocyte, obtains transgenic cloned embryos.Send out finally by transgenic cloned embryos are transplanted to
The recipient cattle intrauterine of feelings, obtains transgene clone cattle.
Concrete involved reagent and material are as follows:Hyclone, puromycin, DMEM, DMEM/F12, Opti-MEM training
Foster base is purchased from Invitrogen companies of the U.S., and EDTA and Trypsin is purchased from Sigma Co., USA, Tissue Culture Plate and culture dish
Purchased from Corning companies of the U.S., plasmid extraction kit and cellular genome extracts kit are purchased from Omega companies of the U.S.,Mutation Detection test kits be purchased from Transgenomic companies, PrimeSTAR archaeal dna polymerases and
Solution I DNA ligases are purchased from Takara companies, and transfection reagent HD DNA Transfection Reagent are purchased from
FuGENE companies, electrotransfection instrument (ECM2001) is purchased from BTX companies of the U.S., and restricted enzyme is purchased from NEB companies, and competence is thin
Born of the same parents DH5 α and JM110 are purchased from Shanghai TIANGEN companies.
1st, the structure of CRISPR/Cas9 carrier for expression of eukaryon
Design and vector construction in 1.1 target practice sites
Select FSCN1 (fascin actin-bundling protein 1, FSCN1) on cow genome No. 25 chromosomes of group
Gene and ACTB (beta-actin, ACTB) intergenic region design target practice site (below or also referred to as F-A target practices site), entirely
A length of 560bp, sequence is following (referring to SEQ.ID.NO.1, be from left to right 5` ends):
Bos Taurus chromosome 25Btau_4.6.1Chr25.position 40,631,870-40,632,
429
By the online screening implement ZiFiT (http in above-mentioned sequence inputting target practice site://zifit.partners.org/
ZiFiT/), will subsequently amount to 80 potential target practice sites and fully enter target practice site online evaluation instrument Cas-OFFinder
(http://www.rgenome.net/cas-offinder/) in, export preliminary the selection result.The present invention is from whole 80
Optimal 14 sites are picked out in individual potential target practice site carries out follow-up CRISPR/Cas9 construction of eukaryotic expression vector works
Make and further cutting efficiency detection.
As shown in figure 1, the unitary expression vector selected by the present invention is both comprising the complete unit needed for hspCas9 protein expressions
Part sequence, also comprising the hU6 promoteres needed for stable transcription sgRNA.The carrier is at restricted enzyme Bbs I enzyme action
After reason, the joint design being cloned into the corresponding go-ahead sequence in site of practicing shooting needed for the carrier can be formed.Synthesize using described in table 1
Oligonucleotide sequences, CRISPR/Cas9 construction of eukaryotic expression vector is capable of achieving with coupled reaction by simple annealing.
SgRNA cloning primer sequences (5'-3') of table 1.
The sequence of underscore portion identification is each target practice site correspondence go-ahead sequence in table 1
Above-mentioned nucleotide sequence is delivered to into the synthesis of Shanghai Sheng Gong biotech firms, following reaction system is built:2μL Top Guide
oligo(100μM);2μL Bottom Guide oligo(100μM);Plus 16 μ L ddH2The μ L cumulative volumes of O to 20.Mix and short
Temporarily after centrifugation, the following program that carries out is placed in PCR instrument:37 DEG C 5 minutes;95 DEG C 10 minutes;Afterwards 5 DEG C of gradient cooling per minute is straight
To 4 DEG C.After completing annealing, taking-up sample is placed in stand-by on ice.
Build Cas9 expression vector plasmid enzyme restriction reaction systems as follows:10 μ L pSpCas9 (BB) -2A-GFP (2 μ g,
Addgene, referring to Fig. 2);2μL 10×NEBuffer 2.1;1μL Bbs I;Plus 7 μ L ddH2The μ L cumulative volumes of O to 20.Mix
And after of short duration centrifugation, 37 DEG C of water-baths are overnight.Reclaim carrier after enzyme action, and with above-mentioned annealing after sample build following linked system:1
Double-strand oligo after μ L annealing;2μL pSpCas9(BB)-2A-GFP;5μL 2×Solution I;Plus 2 μ L ddH2The μ L of O to 10
Cumulative volume.Mix and 16 DEG C of water-baths connect 1h after of short duration centrifugation.Connection product (target site on position be located at hU6 promoteres with
Between sgRNA joint sequence scaffold) it is transformed in competent cell DH5 α by standardization program, coat solid LB media
(100mg/mL ampicillin) upper 37 DEG C of overnight incubations.Hua Da science and technology sequencing is sent to after the several monoclonal amplification culture of picking,
Choose positive colony preservation strain standby.
1.2 cleavage activities are detected
When bovine fetal fibroblast cell (BFFs) is cultivated to degree of converging about 60% in 60mm culture dishs, take respectively each
The μ g of group Cas9 expression vectors plasmid 10;The μ L of FuGENE HD transfection reagents 20;Opti-MEM is added to the μ L of cumulative volume 250.It is fully mixed
Even rear room temperature stationary incubation 15min, transfection mixture is added in each correspondence culture dish, is put back in incubator after soft mixing
Continue to cultivate.After transfection 72h, collect cell and extract genome and carry out using Omega companies full-length genome extracts kit
Follow-up Surveyor mismatch DNAs enzyme detection.To specifications acceptance of the bid quasi-ordering is carried out for operation, wherein PCR amplification target practices region
(1037bp) the primer sequence is as follows, 60 DEG C of annealing temperature:
Surveyor-detect-F 5′-GACTCCTGTAACCTCTGTCCCTG-3′(SEQ.ID.NO.30)
Surveyor-detect-R 5′-TCAGCAGTTGCGGTTCG-3′(SEQ.ID.NO.31)
Nucleic acid electrophoresis result is through software image-J (http://imagej.net) gray scale assessment, calculate cutting effect
Rate fcutTwo band gray scale sums/band gray scale summation of swimming lane three after=enzyme action.In order to preferably reflect Cas9 albumen at this
The actual target practice effect in site, it is actual mutation rate further to be converted cutting efficiency by following algorithm Testing result is shown in Fig. 3.
As a result show, in No. 45 target practice site Cas9 nucleic acid enzyme cleavage activity highests.For identical target practice site,
Cas9 nickases have partial loss compared to Cas9 nucleic acid enzyme cleavage activities, but the former is being repaired outside approach mediation by HDR
The probability for introducing mutation (indels) in the gene targeting insertion process of source in the range of full-length genome is much smaller.Therefore 45 are selected
Number target practice site and single Cas9 nickases carry out follow-up NRAMP1 loading tests, to take into account the high efficiency and essence of gene targeting
Parasexuality, improves the probability of success of transgenic animal production.
Below as do not done explanation in addition, single Cas9 otch nuclease expression vectors are with sequence corresponding to numbering 45 in table 1
The leukorrhagia dashed part of row is used as go-ahead sequence.
2nd, the structure of NRAMP1 macrophages specificity targeting vector pNRAMP1-eGFP-P2A-Puro
The clone of 2.1 genes of interest NRAMP1
According to cattle NRAMP1 sequences (the Gene ID that NCBI is announced:282470) primer amplifying target genes ORF is designed, and
Each element is connected by the restriction enzyme site in the primer in follow-up carrier.Primer sequence is:
NRAMP1-19T-F:5'-ATTTGCGGCCGCGAATTCGTCGACGTGGGGTACC
CATGTCAGGTGACACGGGC-3'(SEQ.ID.NO.32)
NRAMP1-19T-R:5'–AAGCTTCCATGGATCGATGGGACTAGTACGCGTC
GCGGATCCTCATCCCGAGGTCCTCCCCTT-3'(SEQ.ID.NO.33)
Reaction system is as follows:10μL 5×PS Buffer;4μL dNTPs(2.5mmol/L);1μL NRAMP1-19T-F
(10μM);1μL NRAMP1-19T-R(10μM);3 μ L milch cow cDNA (100ng/ μ L);0.5 μ L PrimerStar DNA are polymerized
Enzyme (2.5U/ μ L);Plus distilled water is to 50 μ L cumulative volumes.Response procedures are set according to product description standard three-step approach, wherein moving back
Fiery temperature is 60 DEG C, extension of time 90s.Reclaim PCR purpose fragments and after its end adds A to process, the standard T-A clone of structure connects
Junctor system is recombinated to pMD19T simple cloning vehicles (Takara), in being transformed into commercialization DH5 α escherichia coli, and is chosen
Extra large Hua Da gene sequencing is served after peek monoclonal amplification culture.Correct carrier is sequenced and is temporarily named as pNRAMP1-19T.
The clone of 2.2 NRAMP1 promoteres
According to the cattle NRAMP1 promoter sequence (GenBank that NCBI is announced:AY438096.1 primer sequence) is designed as follows:
Promoter-19T-F:5'-CGCGTCGACCATCACAGCCTCCTACC-3'(SEQ.ID.NO.34)
Promoter-19T-R:5'-TTAAGGTACCGGGTGCTTCCTCTCTAGGC-3'(SEQ.ID.NO.35)
Reaction system is as follows:10μL 5×PS Buffer;4μL dNTPs(2.5mmol/L);1μL Promoter-19T-
F(10μM);1μL Promoter-19T-R(10μM);1 μ L milch cow genomes (200ng/ μ L);0.5μL PrimerStar DNA
Polymerase (2.5U/ μ L);Plus distilled water is to 50 μ L cumulative volumes.According to product description standard three-step approach, response procedures are set, its
Middle annealing temperature is 55 DEG C, extension of time 90s.Reclaim PCR purpose fragments and after its end adds A to process, build standard T-A gram
Grand linked system is recombinated to pMD19T cloning vehicles (Takara), in being transformed into commercialization DH5 α escherichia coli, and picking
Extra large Hua Da gene sequencing is served after several monoclonal amplification culture.
Correct positive recombinant will be sequenced carries out respectively the process of SalI and KpnI double digestions with pNRAMP1-19T carriers,
Above-mentioned promoter sequence is connected on pNRAMP1-19T carriers by Solution I.Positive recombinant vector is temporarily named as
pPromoter-NRAMP1-19T。
The clone of 2.3 homology arm sequences
It is homologous as left side that design primer expands respectively F-A target practices site upstream sequence (777bp) on No. 25 chromosomes of cattle
Arm (Left arm, LA) and downstream sequence (816bp) are used as right side homology arm (Right arm, RA), and primer sequence is as follows:
LA-19T-F:5'-GCGGCCGCGTCTGACCCGTGAGTGTT-3'(SEQ.ID.NO.36)
LA-19T-R:5'-GTCGACGCGGCTAGTTTGGGAGTG-3'(SEQ.ID.NO.37)
RA-19T-F:5'-ATCGATACACCCTTTCTAGTGGTCC-3'(SEQ.ID.NO.38)
RA-19T-R:5'-AAGCTTTCCCGCTGATTGTTCTTC-3'(SEQ.ID.NO.39)
Reaction system is as follows:10μL 5×PS Buffer;4μL dNTPs(2.5mmol/L);1μL primer F(10μ
M);1μL primer R(10μM);1 μ L milch cow genomes (200ng/ μ L);0.5 μ L PrimerStar archaeal dna polymerases
(2.5U/μL);Plus distilled water is to 50 μ L cumulative volumes.Response procedures are set according to product description standard three-step approach, wherein annealing
Temperature is 58 DEG C, extension of time 50s.Reclaim PCR purpose fragments and after its end adds A to process, build the clone's connection of standard T-A
System is recombinated to pMD19T cloning vehicles, and in being transformed into commercialization JM110 escherichia coli, and the several monoclonals of picking expand
Extra large Hua Da gene sequencing is served after culture, sequencing is correctly LA positive recombinants and RA positive recombinants.
LA positive recombinants and pPromoter-NRAMP1-19T carriers are carried out respectively into NotI and SalI double digestions to process,
Left side homology arm is connected on the latter's skeleton carrier by Solution I.Connection product is transformed into into JM110 competence thin
In born of the same parents.NotI and SalI double digestions are identified after positive recombinant, extract plasmid, then respectively enter it with RA positive recombinants
The process of row ClaI and HindIII double digestion, is connected to right side homology arm on the former skeleton carrier by Solution I.By sun
Property recombinant vector is temporarily named as pLA-Promoter-NRAMP1-RA-19T.
The structure of the specific expressed targeting vector pNRAMP1-eGFP-P2A-Puro of 2.4 macrophages
PLA-Promoter-NRAMP1-RA-19T carriers and pEGFP-C1 carriers (Clontech) are carried out into respectively BamHI
With the process of MluI double digestions, the former linearisation skeleton carrier is separately recovered with purpose piece of the latter comprising SV40polyA sequences
Section, is attached by Solution I.Positive recombinant vector is temporarily named as pLA-Promoter-NRAMP1-polyA-RA-
19T。
(the DOI with the existing carrier of this laboratory as template:10.13345/j.cjb.130529), expand selection markers LoxP-
EF1α-EGFP-P2A-Puro-LoxP.Primer sequence is as follows:
EEPP-19T-F:5'-GAGCACTAGTATAACTTCGTATAGCATACATTATACGAAG
TTATTGCGTTATCCCCTGATTCTGT-3'(SEQ.ID.NO.40)
EEPP-19T-R:5'-TACCATCGATGGAACTTCGTATAATGTATGCTATACGAAG
TTATCGCTTACAATTTACGCCTTAAG-3'(SEQ.ID.NO.41)
Reaction system is as follows:10μL 5×PS Buffer;4μL dNTPs(2.5mmol/L);1μL EEPP-19T-F(10
μM);EEPP-19T-R(10μM);1 μ L plasmid templates (200ng/ μ L);0.5 μ L PrimerStar archaeal dna polymerases (2.5U/ μ
L);Plus distilled water is to 50 μ L cumulative volumes.Response procedures are set according to product description standard three-step approach, wherein annealing temperature is 62
DEG C, extension of time 3min.
PCR primer and pLA-Promoter-NRAMP1-polyA-RA-19T carriers are carried out into respectively the double enzymes of SpeI and ClaI
Process is cut, after Solution I connect, positive recombinant vector is preserved after sequencing, that is, complete that macrophage is specific expressed to be beaten
The structure of targeting vector pNRAMP1-eGFP-P2A-Puro, as shown in Figure 4 (i.e. donor vehicle Cas9Donor Vector).In Fig. 4
Shown carrier includes the following element being sequentially arranged:LA, NRAMP1 promoter, NRAMP1 open reading frame, SV40polyA, on
Trip LoxP sites, EF1 α promoteres, fluorescent reporter gene EGFP open reading frame, P2A sequences, resistant gene PURO (anti-purine
Mycin) open reading frame, SV40polyA, downstream LoxP sites and RA.3rd, the specific expressed targeting vector of macrophage
PNRAMP1-eGFP-P2A-Puro and the single Cas9 otch nuclease expression vectors cotransfection bovine fetal fibroblast of specificity
Build nuclear donor cell.
3.1 bovine fetal fibroblast cultures
Bovine fetal fibroblast used is tissue block adherent method gained in the present invention.By the cattle fetus (Yang Ling of collection
Clone limited company of unit of section, 06 month 2013) clean more than three times with the PBS containing mycillin to avoid carefully
Bacterium pollutes.Cattle fetal skin tissue is peeled off with eye scissorss and tweezers on aseptic working platform, and is shredded for about 1mm3Group
Knit block.Careful uniformly attaches piece of tissue in diameter 60mm culture dishs, and a small amount of DMEM culture fluid moistening of soft Deca.Will training
Foster ware is inverted CO237 DEG C in incubator, 5%CO2After incubation 4h, the DMEM cultures for adding 5mL to contain mycillin and 10%FBS
Liquid is just putting culture.There is fibroblast to move out around visible tissue block after about 3-4 days, continue culture to cell confluency degree and be more than
Remnant tissue's block is discarded after 90%, freeze-stored cell or Secondary Culture now may be selected, as shown in Figure 5A.
Secondary Culture with it is frozen:Cell culture fluid is discarded, adds 3mL PBS to abandon liquid after softly washing, add 1mL to contain
The PBS peptic cells of 0.25% pancreatin, add DMEM culture fluid to terminate digestion after 37 DEG C of incubation 3min.Soft piping and druming is peeled off adherent
Cell forms cell suspension, selects to add DMEM culture fluid re-suspended cells after centrifugation supernatant discarded, according to 1:3~1:5 ratio
Secondary Culture, as shown in Figure 5 B;Or select to add the cells frozen storing liquid containing 10%DMSO, thorough re-suspended cell simultaneously to proceed to cryopreservation tube
And it is in program freezing storing box and frozen in final transposition liquid nitrogen.Cell recovery:Cryopreservation tube is taken out from liquid nitrogen, 37 DEG C of water-baths are fast
Speed is thawed.Frozen stock solution is discarded after low-speed centrifugal, DMEM culture fluid thorough re-suspended cells of the 1mL containing 10%FBS is added.It is right to be forwarded to
In answering specification culture dish, 37 DEG C are placed in, 5%CO2Cultivate in incubator.
The screening of 3.2 positive cell clones
The present invention uses electroporation by targeting vector pNRAMP1-eGFP-P2A-Puro and the single Cas9 otch of specificity
Nuclease expression vectors cotransfection enters bovine fetal fibroblast.Electricity turns formula of liquid for KCl:120mM;CaCl2:0.15mM;
K2HPO4:10mM;MgCl2:2.50mM.PH value is adjusted to after 7.6, with Opti-MEM culture fluid according to volume ratio 3:1 mixes.To
The each 20 μ g of above two vector plasmid are added in 500 μ L mixed liquors, in being transferred to the cell mass that centrifugation discards culture fluid, gently
Piping and druming re-suspended cell is simultaneously mixed.Above-mentioned cell suspension is transferred in new BTX electricity revolving cups and stands 5min, adjust electroporation voltage
For 510V, pulse 1ms to shock by electricity and stand 10min after 3 times.Cell suspension is transferred in 90mm culture dishs, in 37 °, 5% CO2
Continue to cultivate in incubator.
After transfection 24h, the puromycin of final concentration of 2 μ g/mL is added in cell culture fluid carries out drug screening.Screening
After 8d, the complete cell death of targeting vector is not integrated in genome, and the cell of stable integration targeting vector gradually forms list
Clone cell group, and the visible green luciferase expression under fluorescence microscope.Monoclonal cell is shown in Fig. 6.Picking monoclonal cell is extremely
48 orifice plates continue to cultivate and proceed follow-up positive clone identification.
3.3 PCR identify the positive cell clone of gene targeting
Take the monoclonal cell of partial enlargement culture, centrifugation abandon after supernatant add 20 μ L lysates (10mM Tris-HCl,
pH 8.5;50mM KCl;1.5mM MgCl2;0.5%NP-40;0.5%Tween-20;400g/mL proteinase K), fill
Resuspended rear 65 DEG C of water-bath 30min, 95 DEG C of water-bath 15min are divided to complete cell lysis.5 μ L cell lysates are taken as template, difference
Positive clone identification is carried out using following junctionPCR primers.
5'-junction:Lj F(5'-AGTTGTGCCCTCCGTGTA-3'),SEQ.ID.NO.42;
Lj R(5'-CTGCCATGCCCACTCAT-3'),SEQ.ID.NO.43;
3'-junction,Rj F(5'-GCGCATGGCCGAGTTGA-3'),SEQ.ID.NO.44;
Rj R(5'-CCCGCATTGCTCCCTCT-3'),SEQ.ID.NO.45。
Wherein, 5'-junction forward primer matching sequence be 5' ends homology arm upstream gene group sequence, downstream primer
It is NRAMP1 gene promoter sequences on targeting vector, primer size 1578bp with sequence;3'-junction forward primer is matched
Sequence be targeting vector on puro gene orders, downstream primer matching sequence be 3' ends homology arm downstream genomic sequence, product
Size should be 1978bp, as shown in Figure 7.The positive colony identified by 5'-junction PCR reactions further passes through 3'-
Junction PCR are identified.Only follow-up reality just can be carried out after amplification culture by the clone of two-wheeled PCR identifications
Test.Typically see Fig. 8 using junction PCR qualification processes.
3.4 Southern blotting identify the cell clone of gene targeting
Part cell extraction genomic DNA will be taken after the above-mentioned positive colony cell expansion culture for identifying, used
HindIII is carried out after sufficient endonuclease reaction, respectively with the targeting 5' ends homology arm upstream gene group sequence of digoxigenin labeled
The probe (probe 2) of puro gene orders is hybridized on probe (probe 1) and targeting targeting vector.Probe sequence is distinguished
Enter performing PCR amplification by following primer to obtain, digoxigenin labeled process passes through DIG-High Prime DNA Labeling and
Detection Starter Kit II (Roche) test kits are completed.
Probe 1,p1F(5'-CCAGTTCTTTGATGGGTGT-3'),SEQ.ID.NO.46;
p1R(5'-GGCTTGACAGAAGGGTATG-3'),SEQ.ID.NO.47;
Probe 2,p2F(5'-AGCAAGCAGGAGACGTGGAA-3'),SEQ.ID.NO.48;
p2R(5'-CGCTCGTAGAAGGGGAGGTT-3'),SEQ.ID.NO.49。
As shown in figure 9, F-A target practices site occurs the positive colony of accurate gene insertion can hybridize the band of 1.58kb
(probe1) and 9.05kb band (probe2).And when using probe 1, it is miscellaneous that the band of 3.84kb indicates the clone
Close, still remain the normal chromosomal of a wild type.Statistics shows, carries out NRAMP1 using said method and practice shooting what is inserted
Positive rate is 18.11%, and the ratio is sufficiently high for transgenic animal production.
4th, with above-mentioned genome site-directed integration the bovine fetal fibroblast of genes of interest NRAMP1 as nuclear donor cell,
Build transgene clone cattle
The maturation culture of 4.1 oocytes
Ovary used of the invention is under aseptic condition and picks up from Xi'an slaughterhouse (in October, 2014-January), in 37 DEG C of nothings
Transport to laboratory in bacterium normal saline.Extract the follicle of 3~8mm diameters and collect cumulus oocyte complex, stereoscopic
Suitable oocyte is selected under microscope for maturation culture.Maturation culture solution is the epidermis for adding 10%FBS and 10ng/mL
The TCM199 (Gibico) of somatomedin.At 38.5 degrees Celsius, 5%CO2Under the conditions of cultivate 20h after, with 0.2% hyaluronic acid
Enzyme removes cumulus cell, and selects the oocyte of maturation for nuclear transfer experiments.
The structure of 4.2 transgene clone embryos
The present invention takes and donorcellses is transferred to into the nuclear maturation of removal using body-cell neucleus transplanting (SCNT) technology
In oocyte.Internal diameter is used as micrurgy liquid with the PBS containing 10%FBS, 5 μ g/mL cytochalasin Bs during nuclear transplantation
20 μm of enucleation pipe suctions out first polar body and part kytoplasm on micrurgy instrument.Dyeed with 10 μ g/mL Hoechst 33342
After 10min, complete non-nucleus egg mother cell is chosen under fluorescence microscope;The ovum for removing first polar body and chromosome completely is female thin
Born of the same parents are used for nuclear transplantation.
The positive transgenic Holstein cow fetus that NRAMP1 after to grow to contact inhibition state 3d is precisely inserted is into fibre
Dimension cell is donor cell.With enucleation pipe by under the successful oocyte zona pellucida of donorcellses injection enucleation.Using electro' asion
Liquid by caryoplasm complex balance 3min, be connected with micrurgy instrument microelectrode tip arrangement recombinant, make film contact surface and
The line of two electrodes is vertical, and gives 28V, 10 μm of electric pulses and carry out electro' asion.Recombinant after fusion is placed in containing 10%
In the M199 of FBS, 38.5 DEG C, 5%CO2 culture 2h after observe fusion situation.
The activation of 4.3 transgene clone embryos and In vitro culture
After the reconstituted embryo of fusion balances 2h in the M199 containing 10%FBS, (SIGMA is purchased from containing 5 μm of ol/L ionomycins
Company) mSOFaa culture fluid (be purchased from SIGMA companies) process 5min, then in the (6- of dimethylaminopurine containing 2mmol/L
DMAP culture 4h in mSOFaa culture fluid), proceeds to mineral oil and covers and in advance in CO after cleaning 3 times2Balance in incubator to
Cultivate in the mSOFaa of few 2h, culture density is 5 μ L each reconstituted embryo, in 38.5 DEG C, 5%CO2, cultivate under saturated humidity,
Check blastaea developmental state within 7th day.The transgene clone embryo of normal development to blastaea is as shown in Figure 10.
The preparation of 4.4 transgene clone cattle
Well-developed blastaea is transplanted to cornua uteri (every 2-3 piece of recipient cattle transplanting of the He Sitan recipient cattles of heat
Blastaea).After 60 days, pregnant inspection is done to the recipient cattle that feelings are not returned after transplanting with B ultrasonic.Hereafter monthly check once, observation gestation
Maintenance situation.After 10 months, the transgene clone cattle (Figure 11) of the gene targeting for surviving successfully is given birth to.F-A target practices site pinpoints
Being successfully prepared for the transgene clone cattle of integration NRAMP1 genes, is that prevention prapess lay a solid foundation.
Nucleotides sequence list
<110>Xibei Univ. of Agricultural & Forest Science & Technology
<120>NRAMP1 fixed point insertions are mediated to obtain the side of transgenic cow fetal fibroblast using single Cas9 nickases
Method
<160> 49
<210> 1
<211> 560
<212> DNA
<213> Bos taurus
<400> 1
aagaaccttg cccttgtcca ggaatccagg ggggcttcct ggaagaggtg atatgtacac 60
caaaccctaa aggagaagca gaacttaaag aagcagaaag gatgcgtgtg gggagcagag 120
tccattacag accgagagaa caggaagggc agaggccctg aggcagattt ggtgttctaa 180
ggattagaag gcagagtgtc tgggaacaca gagtaaggct ggaggggcaa gggggtgagg 240
ttagccacac tcccaaacta gccgcggtct ccacaactat gtgcagtgtc gacgtgcagc 300
tccttgaatt gccactcaca ggttcccagc acccagatcg acgtacaggc ctagggttcc 360
agaagcttcc atcacaccct ttctagtggt cctccacata gggcaccttt gtcctgtctt 420
ctgcacatag attggctccc tgtctttaaa ctccacgaaa acaggatcag agagaatccg 480
ttcttgtgtg tgaagtggga gctcactgtg gtttgcattt gcatttcacg gatgacccgt 540
gatgtcgagt ctcttcttat 560
<210> 2
<211> 25
<212> DNA
<213>Synthetic
<400> 2
caccgaacct gtgagtggca attca 25
<210> 3
<211> 25
<212> DNA
<213>Synthetic
<400> 3
aaactgaatt gccactcaca ggttc 25
<210> 4
<211> 25
<212> DNA
<213>Synthetic
<400> 4
caccgatgtg gaggaccact agaaa 25
<210> 5
<211> 25
<212> DNA
<213>Synthetic
<400> 5
aaactttcta gtggtcctcc acatc 25
<210> 6
<211> 25
<212> DNA
<213>Synthetic
<400> 6
caccgcagat cgacgtacag gccta 25
<210> 7
<211> 25
<212> DNA
<213>Synthetic
<400> 7
aaactaggcc tgtacgtcga tctgc 25
<210> 8
<211> 25
<212> DNA
<213>Synthetic
<400> 8
caccgcagca cccagatcga cgtac 25
<210> 9
<211> 25
<212> DNA
<213>Synthetic
<400> 9
aaacgtacgt cgatctgggt gctgc 25
<210> 10
<211> 25
<212> DNA
<213>Synthetic
<400> 10
caccgcagga caaaggtgcc ctatg 25
<210> 11
<211> 25
<212> DNA
<213>Synthetic
<400> 11
aaaccatagg gcacctttgt cctgc 25
<210> 12
<211> 25
<212> DNA
<213>Synthetic
<400> 12
caccgccaca ctcccaaact agccg 25
<210> 13
<211> 25
<212> DNA
<213>Synthetic
<400> 13
aaaccggcta gtttgggagt gtggc 25
<210> 14
<211> 25
<212> DNA
<213>Synthetic
<400> 14
caccgcctag gcctgtacgt cgatc 25
<210> 15
<211> 25
<212> DNA
<213>Synthetic
<400> 15
aaacgatcga cgtacaggcc taggc 25
<210> 16
<211> 25
<212> DNA
<213>Synthetic
<400> 16
caccgcctgt cttctgcaca tagat 25
<210> 17
<211> 25
<212> DNA
<213>Synthetic
<400> 17
aaacatctat gtgcagaaga caggc 25
<210> 18
<211> 25
<212> DNA
<213>Synthetic
<400> 18
caccgctagg cctgtacgtc gatct 25
<210> 19
<211> 25
<212> DNA
<213>Synthetic
<400> 19
aaacagatcg acgtacaggc ctagc 25
<210> 20
<211> 25
<212> DNA
<213>Synthetic
<400> 20
caccgctgta cgtcgatctg ggtgc 25
<210> 21
<211> 25
<212> DNA
<213>Synthetic
<400> 21
aaacgcaccc agatcgacgt acagc 25
<210> 22
<211> 25
<212> DNA
<213>Synthetic
<400> 22
caccggacaa aggtgcccta tgtgg 25
<210> 23
<211> 25
<212> DNA
<213>Synthetic
<400> 23
aaacccacat agggcacctt tgtcc 25
<210> 24
<211> 25
<212> DNA
<213>Synthetic
<400> 24
caccggtgga gaccgcggct agttt 25
<210> 25
<211> 25
<212> DNA
<213>Synthetic
<400> 25
aaacaaacta gccgcggtct ccacc 25
<210> 26
<211> 25
<212> DNA
<213>Synthetic
<400> 26
caccgtgtac gtcgatctgg gtgct 25
<210> 27
<211> 25
<212> DNA
<213>Synthetic
<400> 27
aaacagcacc cagatcgacg tacac 25
<210> 28
<211> 25
<212> DNA
<213>Synthetic
<400> 28
caccgtgtgg agaccgcggc tagtt 25
<210> 29
<211> 25
<212> DNA
<213>Synthetic
<400> 29
aaacaactag ccgcggtctc cacac 25
<210> 30
<211> 23
<212> DNA
<213>Synthetic
<400> 30
gactcctgta acctctgtcc ctg 23
<210> 31
<211> 17
<212> DNA
<213>Synthetic
<400> 31
tcagcagttg cggttcg 17
<210> 32
<211> 53
<212> DNA
<213>Synthetic
<400> 32
atttgcggcc gcgaattcgt cgacgtgggg tacccatgtc aggtgacacg ggc 53
<210> 33
<211> 63
<212> DNA
<213>Synthetic
<400> 33
aagcttccat ggatcgatgg gactagtacg cgtcgcggat cctcatcccg aggtcctccc 60
ctt 63
<210> 34
<211> 26
<212> DNA
<213>Synthetic
<400> 34
cgcgtcgacc atcacagcct cctacc 26
<210> 35
<211> 29
<212> DNA
<213>Synthetic
<400> 35
ttaaggtacc gggtgcttcc tctctaggc 29
<210> 36
<211> 26
<212> DNA
<213>Synthetic
<400> 36
gcggccgcgt ctgacccgtg agtgtt 26
<210> 37
<211> 24
<212> DNA
<213>Synthetic
<400> 37
gtcgacgcgg ctagtttggg agtg 24
<210> 38
<211> 25
<212> DNA
<213>Synthetic
<400> 38
atcgatacac cctttctagt ggtcc 25
<210> 39
<211> 24
<212> DNA
<213>Synthetic
<400> 39
aagctttccc gctgattgtt cttc 24
<210> 40
<211> 65
<212> DNA
<213>Synthetic
<400> 40
gagcactagt ataacttcgt atagcataca ttatacgaag ttattgcgtt atcccctgat 60
tctgt 65
<210> 41
<211> 66
<212> DNA
<213>Synthetic
<400> 41
taccatcgat ggaacttcgt ataatgtatg ctatacgaag ttatcgctta caatttacgc 60
cttaag 66
<210> 42
<211> 18
<212> DNA
<213>Synthetic
<400> 42
agttgtgccc tccgtgta 18
<210> 43
<211> 17
<212> DNA
<213>Synthetic
<400> 43
ctgccatgcc cactcat 17
<210> 44
<211> 17
<212> DNA
<213>Synthetic
<400> 44
gcgcatggcc gagttga 17
<210> 45
<211> 17
<212> DNA
<213>Synthetic
<400> 45
cccgcattgc tccctct 17
<210> 46
<211> 19
<212> DNA
<213>Synthetic
<400> 46
ccagttcttt gatgggtgt 19
<210> 47
<211> 19
<212> DNA
<213>Synthetic
<400> 47
ggcttgacag aagggtatg 19
<210> 48
<211> 20
<212> DNA
<213>Synthetic
<400> 48
agcaagcagg agacgtggaa 20
<210> 49
<211> 20
<212> DNA
<213>Synthetic
<400> 49
cgctcgtaga aggggaggtt 20
Claims (10)
1. the specific expressed targeting vector of a kind of NRAMP1 macrophages, it is characterised in that:The targeting vector includes genes of interest
NRAMP1 and for by NRAMP1 genes by homologous recombination fixed point insertion cattle No. 25 chromosomes FSCN1 and ACTB it is intergenic
Element sequences.
2. the specific expressed targeting vector of a kind of NRAMP1 macrophages according to claim 1, it is characterised in that:The unit
Part sequence includes that for the homology arm sequence of site homologous recombination of practicing shooting homology arm with cow genome group as template amplification, produce by amplification
Thing is respectively the upstream 577-977bp and downstream 616-1016bp in target practice site on No. 25 chromosomes of cattle;Target practice site is located at cattle
In sequence between No. 25 chromosome FSCN1 and ACTB genes as shown in SEQ.ID.NO.1.
3. the specific expressed targeting vector of a kind of NRAMP1 macrophages according to claim 1, it is characterised in that:The mesh
Gene NRAMP1 be by external source expand NRAMP1 genes its own promoter start transcription.
4. the specific expressed targeting vector of a kind of NRAMP1 macrophages according to claim 1, it is characterised in that:The unit
Part sequence also includes selection markers eGFP gene and PURO genes, and the two riddled basins are all started by EF1 α promoteres and turned
Record, and expressed by self cleavage peptide P2A sequences fused in tandem.
5. the specific expressed targeting vector of a kind of NRAMP1 macrophages according to claim 4, it is characterised in that:The unit
Part sequence also includes being located at two LoxP sequences in the same direction of two riddled basins both sides.
6. a kind of construction method of the bovine fetal fibroblast of insertion genes of interest NRAMP1, it is characterised in that:Including following
Step:With bovine fetal fibroblast as host cell, by cotransfection targeting vector pNRAMP1-eGFP-P2A-Puro and pin
Air exercise target site single CRISPR/Cas9 nickases expression vector, by genes of interest NRAMP1 site-directed integrations to cattle fetus into
Between fibrocellular No. 25 chromosomes FSCN1 and ACTB gene.
7. method according to claim 6, it is characterised in that:The host cell is the holstein cow for passing on for 2~3 generations
Fetal fibroblast.
8. method according to claim 6, it is characterised in that:The cotransfection operation adopts electroporation.
9. method according to claim 6, it is characterised in that:The single CRISPR/Cas9 nickases expression vector bag
Containing the go-ahead sequence corresponding with target practice site, target practice site is located between No. 25 chromosome FSCN1 and ACTB genes of cattle such as
In sequence shown in SEQ.ID.NO.1.
10. method according to claim 6, it is characterised in that:The cattle fetus of the insertion genes of interest NRAMP1 is into fibre
Dimension cell can be used as the nuclear transplantation operation donorcellses of production transgene clone cattle.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611001075.7A CN106591364B (en) | 2016-11-14 | 2016-11-14 | A method of obtaining transgenic cow fetal fibroblast |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611001075.7A CN106591364B (en) | 2016-11-14 | 2016-11-14 | A method of obtaining transgenic cow fetal fibroblast |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106591364A true CN106591364A (en) | 2017-04-26 |
CN106591364B CN106591364B (en) | 2018-12-25 |
Family
ID=58590004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611001075.7A Active CN106591364B (en) | 2016-11-14 | 2016-11-14 | A method of obtaining transgenic cow fetal fibroblast |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106591364B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107619837A (en) * | 2017-09-20 | 2018-01-23 | 西北农林科技大学 | The method that nuclease-mediated Ipr1 fixed points insertion acquisition transgenic cow fetal fibroblast is cut using Cas9 |
CN114525304A (en) * | 2020-11-23 | 2022-05-24 | 南京启真基因工程有限公司 | Gene editing method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102559749A (en) * | 2010-12-17 | 2012-07-11 | 西北农林科技大学 | Integration cattle NRAMPl macrophage specificity expression vector/cattle fibroblast and method thereof |
CN103224947A (en) * | 2013-04-28 | 2013-07-31 | 陕西师范大学 | Gene targeting system |
CN104651402A (en) * | 2015-03-18 | 2015-05-27 | 湖北省农业科学院畜牧兽医研究所 | General type gene targeting vector |
-
2016
- 2016-11-14 CN CN201611001075.7A patent/CN106591364B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102559749A (en) * | 2010-12-17 | 2012-07-11 | 西北农林科技大学 | Integration cattle NRAMPl macrophage specificity expression vector/cattle fibroblast and method thereof |
CN103224947A (en) * | 2013-04-28 | 2013-07-31 | 陕西师范大学 | Gene targeting system |
CN104651402A (en) * | 2015-03-18 | 2015-05-27 | 湖北省农业科学院畜牧兽医研究所 | General type gene targeting vector |
Non-Patent Citations (1)
Title |
---|
方锐等: "CRISPR/Cas9 介导的基因组定点编辑技术", 《生物化学与生物物理进展》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107619837A (en) * | 2017-09-20 | 2018-01-23 | 西北农林科技大学 | The method that nuclease-mediated Ipr1 fixed points insertion acquisition transgenic cow fetal fibroblast is cut using Cas9 |
CN114525304A (en) * | 2020-11-23 | 2022-05-24 | 南京启真基因工程有限公司 | Gene editing method |
CN114525304B (en) * | 2020-11-23 | 2023-12-22 | 南京启真基因工程有限公司 | Gene editing method |
Also Published As
Publication number | Publication date |
---|---|
CN106591364B (en) | 2018-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107619837A (en) | The method that nuclease-mediated Ipr1 fixed points insertion acquisition transgenic cow fetal fibroblast is cut using Cas9 | |
CN105907758B (en) | CRISPR-Cas9 guide sequence and primer thereof, transgenic expression vector and construction method thereof | |
CN106191113B (en) | Preparation method of MC3R gene knockout pig | |
CN106191064B (en) | A method of preparing MC4R gene knock-out pig | |
CA3060630A1 (en) | Methods for generating genetically modified animals | |
EP3728600A1 (en) | Method for base editing in plants | |
CN104293833B (en) | A kind of special targeting vector of Sp110 macrophages and recombinant cell mediated based on TALEN | |
CN111778252B (en) | SgRNA for targeted knockout of SST gene, CRISPR/Cas9 system and application thereof | |
CN110093354A (en) | A kind of seed separation method of fixed plant hybrid advantage | |
WO2019154437A1 (en) | Crispr/cas9 vector combination and application thereof in gene knockout | |
CN102432679A (en) | Rice extensin OsPEX1 and application thereof | |
CN110643636A (en) | Megalobrama amblycephala MSTNa & b gene knockout method and application | |
CN106148406B (en) | Pig ApoE gene knockout carrier and its construction method and application | |
CN111808887A (en) | Method for preparing double-muscle gluteal beef cattle similar to natural mutation Belgian blue cattle | |
CN106591364B (en) | A method of obtaining transgenic cow fetal fibroblast | |
CN113403337A (en) | Carrier system, method for preparing pig fibroblast and gene editing pig | |
CN106282230A (en) | The method of rite-directed mutagenesis LDLR gene | |
WO2018205641A1 (en) | Cold-resistant and lean-type transgenic pig and preparation method therefor | |
CN114480497B (en) | Construction and application method of ep400 gene knockout zebra fish heart failure model | |
KR101068479B1 (en) | alpha 1,3-galactosyltransferase gene targeting vector and uses thereof | |
CN111778288A (en) | Method, composition and application for constructing HBV transgenic mouse model | |
CN110878314A (en) | Hl-2 gene for regulating and controlling tomato trichome and application thereof | |
CN118166038B (en) | Method for constructing immunodeficiency animal model | |
CN112941108B (en) | Preparation method of Holstein cattle with polled Pc locus homozygous genotype | |
CN113667674B (en) | Paired editing site for targeted excision of pig CD164 gene coding region DNA, use method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |